person

Mireia D. T. R.

Country
Spain
Department
Pediatric Neurology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
11
Sites with multiple studies

Has run more than one trial at 11 of 30 partner sites.

Specializations

Lysosomal Storage Disorders

This investigator specializes in treating rare lysosomal storage disorders, with particular focus on Metachromatic Leukodystrophy (MLD) and Niemann-Pick type C disease. Their research extends to various forms of gangliosidoses, including GM1 and GM2 variants.

  • Late Infantile MLD Treatment
  • GM1/GM2 Gangliosidosis Management
  • Niemann-Pick Disease Therapeutics

Their work involves innovative therapeutic approaches for treating these progressive neurological conditions.

Mucopolysaccharidosis Research

The investigator has extensive experience in treating various forms of Mucopolysaccharidosis, particularly focusing on MPS II and MPS IIIA. Their research encompasses both neuronopathic and non-neuronopathic manifestations of these disorders.

  • MPS II Treatment Development
  • MPS IIIA Gene Therapy
  • CNS-targeted Therapeutics

Their research emphasizes long-term safety and efficacy evaluations in pediatric and young adult populations.

Metabolic Disorders

The investigator specializes in treating genetic metabolic conditions, with particular expertise in Ornithine Transcarbamylase (OTC) deficiency. Their research focuses on developing innovative therapeutic approaches for late-onset metabolic disorders.

  • OTC Deficiency Management
  • Gene Transfer Technologies
  • Metabolic Disease Therapeutics

Their work includes investigating novel gene therapy approaches for treating inherited metabolic disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.